Clinical Trial

Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia

Name: Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia — clinical trial record (NCT07689162)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find out which pain medication is more effective in reducing pain after nose surgery (rhinoplasty). The investigators are looking to find the best treatment to reduce discomfort and improve the healing process for patients having nose surgery.

Trial Details

NCT Number	NCT07689162
Lead Sponsor	Washington University School of Medicine
Conditions	Pain, Postoperative
Enrollment	45 participants
Start Date	2026-07
Primary Completion	2027-06 (estimated)
Study Completion	2027-07 (estimated)
Updated on ClinicalTrials.gov	2026-07-10